| 2 | Therapeutic strategies for targeting cancer stem cells显示文摘The therapeutic limitations of conventional chemotherapeutic drugs present a challenge for cancer therapy;these shortcomings are largely attributed to the ability of cancer cells to repopulate and metastasize after initial therapies.Compelling evidence suggests that cancer stem cells(CSCs)have a crucial impact in current shortcomings of cancer therapy because they are largely responsible for tumor initiation,relapse,metastasis,and chemo-resistance.Thus,a better understanding of the properties and mechanisms underlying CSC resistance to treatments is necessary to improve patient outcomes and survival rates.In this review,the authors characterize and compare different CSC-specific biomarkers that are present in various types of tumors.We further discuss multiple targeting approaches currently in preclinical or clinical testing that show great potential for targeting CSCs.This review discusses numerous strategies to eliminate CSCs by targeting surface biomarkers,regulating CSC-associated oncogenes and signaling pathways,inhibiting drug-efflux pumps involved in drug resistance,modulating the tumor microenvironment and immune system,and applying drug combination therapy using nanomedicine. | Yu Jeong Kim Elizabeth L.Siegler Natnaree Siriwon Pin Wang | 2016 | Journal of Cancer Metastasis and Treatment2016，2，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员